Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × ibritumomab tiuxetan × Clear all

Sponsor

Conditions

Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, Follicular 10 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 7 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma, Large-Cell, Immunoblastic 4 Waldenstrom Macroglobulinemia 3 Lymphoma, Large-Cell, Anaplastic 3 Burkitt Lymphoma 3 Lymphoma, B-Cell 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Orbital lymphoma 1 Oncology Patients Receiving Chemotherapy 1 Neoplasms by Histologic Type 1 Neoplasms 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphatic Diseases 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1

Interventions

Cyclophosphamide 32 Dexamethasone 30 Rituximab 22 Cytarabine 21 fludarabine phosphate 20 Methotrexate 17 Lenalidomide 17 fludarabine 15 Bortezomib 15 Peripheral Blood Stem Cell Transplantation 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Etoposide 13 pembrolizumab 12 Melphalan 12 Filgrastim 12 Paclitaxel 11 Gemcitabine 11 Cyclosporine 11 Carboplatin 11 pomalidomide 10 Busulfan 10 Vincristine 9 carfilzomib 8 Tacrolimus 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Brentuximab Vedotin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡